<div class="container">

<table style="width: 100%;"><tr>
<td>ecog1684</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Phase III Melanoma clinical trial.</h2>

<h3>Description</h3>

<p>Melanoma data from the phase III Eastern Cooperative
Oncology Group (ECOG) two-arm clinical trial studied in
Kirkwood et al. (1996).
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(ecog1684)
</code></pre>


<h3>Format</h3>

<p>A data frame with 284 rows and 5 columns.
</p>

<dl>
<dt><code>trt</code></dt>
<dd>
<p>Treatment: <code>0</code>=control,
<code>1</code>=Interferon alpha-2b (IFN).</p>
</dd>
<dt><code>time</code></dt>
<dd>
<p>Relapse-free survival (in years).</p>
</dd>
<dt><code>status</code></dt>
<dd>
<p><code>1</code>=death or relapse, <code>0</code>=censored.</p>
</dd>
<dt><code>age</code></dt>
<dd>
<p>Age centered to the mean.</p>
</dd>
<dt><code>sex</code></dt>
<dd>
<p><code>0</code>=Male, <code>1</code>=Female.</p>
</dd>
</dl>
<h3>Source</h3>

<p><a href="https://CRAN.R-project.org/package=smcure">https://CRAN.R-project.org/package=smcure</a>
</p>


<h3>References</h3>

<p>Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S.,
Smith, T. J., Borden, E. C. and Blum, R. H. (1996). Interferon alfa-2b
adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern
Cooperative Oncology Group Trial EST 1684.
<em>Journal of clinical oncology</em> <strong>14</strong>(1): 7-17.
</p>
<p>Corbiere, F. and Joly, P. (2007). A SAS macro for parametric
and semiparametric mixture cure models. <em>Computer methods and programs
in Biomedicine</em> <strong>85</strong>(2): 173-180.
</p>


</div>